Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

IAMIambic Therapeutics, Inc.

Nasdaq · CIK 0001997038
Filer category<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts104

Identity from submissions API

NameIambic Therapeutics, Inc.
CIK0001997038
TickersIAM
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN843364168
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(626) 592-2520
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
5627 OBERLIN DRIVE, SUITE 120
SAN DIEGO
CA
92121
CA
Mailing address
5627 OBERLIN DRIVE, SUITE 120
SAN DIEGO
CA
92121
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

49 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 10-Q 10-Q 0001193125-26-468537 001-43509 261574776 34 10942843 1 1
2026-11-16 8-K 8-K 2.02,9.01 0001193125-26-462184 001-43509 261555583 34 559945 1 1
2026-11-09 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001441449-26-000012 005-96006 261534430 34 6784
2026-10-19 4 PRIMARY DOCUMENT 0001958125-26-000011 30006
2026-10-19 4 xslF345X06/form4-10192026_111012.xml 0002154030-26-000007 21759
2026-10-19 4 xslF345X06/form4-10192026_111033.xml 0001855980-26-000009 7175
2026-10-19 4 xslF345X06/form4-10192026_111025.xml 0001205903-26-000013 18739
2026-10-19 4 xslF345X06/form4-10192026_111032.xml 0002151678-26-000007 19976
2026-10-16 8-K 8-K 5.03,7.01,9.01 0001193125-26-424242 001-43509 261466850 34 435404
2026-10-16 4 xslF345X06/form4-10162026_081039.xml 0001252524-26-000005 5467
2026-10-16 4 xslF345X06/form4-10162026_081020.xml 0002154030-26-000005 5466
2026-10-16 4 xslF345X06/form4-10162026_081043.xml 0001323304-26-000010 5439
2026-10-16 4 xslF345X06/form4-10162026_081055.xml 0001377202-26-000012 5460
2026-10-16 4 xslF345X06/form4-10162026_081001.xml 0001205903-26-000011 5508
2026-10-16 4 xslF345X06/form4-10162026_081024.xml 0002151678-26-000005 5450
2026-10-16 4 xslF345X06/form4-10162026_081020.xml 0001855980-26-000007 7385
2026-10-16 4 xslF345X06/form4-10162026_081057.xml 0002155824-26-000005 7378
2026-10-16 4 xslF345X06/form4-10162026_081058.xml 0001864141-26-000007 7337
2026-10-16 4 xslF345X06/form4-10162026_081041.xml 0002156015-26-000005 7388
2026-10-16 4 xslF345X06/form4-10162026_081045.xml 0002034921-26-000007 7386
2026-10-15 424B4 424B4 0001193125-26-422865 333-299057 261463096 33 46467158
2026-10-15 S-8 S-8 0001193125-26-421986 333-299460 261461000 33 372896 1 1
2026-10-14 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003244 333-299057 261461201 33 1755
2026-10-14 3 PRIMARY DOCUMENT 0001958125-26-000010 19285
2026-10-14 3 xslF345X06/form3-10142026_101037.xml 0001252524-26-000003 7224
2026-10-14 3 xslF345X06/form3-10142026_101050.xml 0002154030-26-000003 16495
2026-10-14 3 xslF345X06/form3-10142026_101008.xml 0001323304-26-000008 8505
2026-10-14 3 xslF345X06/form3-10142026_101007.xml 0001377202-26-000010 8503
2026-10-14 3 xslF345X06/form3-10142026_101012.xml 0001205903-26-000009 16071
2026-10-14 3 xslF345X06/form3-10142026_101032.xml 0002151678-26-000003 14034
2026-10-14 3 xslF345X06/form3-10142026_101045.xml 0001781290-26-000003 8526
2026-10-14 3 xslF345X06/form3-10142026_101057.xml 0001855980-26-000005 12365
2026-10-14 3 xslF345X06/form3-10142026_101006.xml 0002155824-26-000003 10709
2026-10-14 3 xslF345X06/form3-10142026_101019.xml 0001864141-26-000005 10674
2026-10-14 3 xslF345X06/form3-10142026_101058.xml 0002156015-26-000003 15798
2026-10-14 3 xslF345X06/form3-10142026_101008.xml 0002034921-26-000005 14756
2026-10-14 CERT 8A_Cert_IAM_1997038.pdf 0001354457-26-000988 001-43509 261459015 34 181061
2026-10-13 8-A12B 8-A12B 0001193125-26-420387 001-43509 261456836 34 30757
2026-10-08 S-1/A S-1/A 0001193125-26-417416 333-299057 261448293 33 48556650 1 1
2026-09-21 S-1 S-1 0001193125-26-396704 333-299057 261394235 33 57188935 1 1
2026-09-09 D xslFormDX01/primary_doc.xml 06b 0001997038-26-000002 021-596810 261367363 33 16169
2026-08-28 DRS/A filename1.htm 0001193125-26-374173 377-09598 261339224 33 50109785
2026-07-24 DRS filename1.htm 0001193125-26-315779 377-09598 261201038 33 62609555
2026-04-08 D xslFormDX01/primary_doc.xml 06b 0001997038-26-000001 021-579622 26849026 33 15239
2025-11-21 D xslFormDX01/primary_doc.xml 06b 0001997038-25-000002 021-564708 251505753 33 15242
2024-06-06 D/A xslFormDX01/primary_doc.xml 06b 0001997038-24-000003 021-511607 241024335 33 12804
2024-05-07 D/A xslFormDX01/primary_doc.xml 06b 0001997038-24-000002 021-511607 24922223 33 12801
2024-04-25 D xslFormDX01/primary_doc.xml 06b 0001997038-24-000001 021-511607 24875673 33 12707
2023-10-12 D xslFormDX01/primary_doc.xml 06b 0001997038-23-000001 021-494624 231323304 33 12673

Latest XBRL company facts

One latest value per concept from companyfacts (104 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 48.93M 2026-11-16 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
ffd NetFeeAmt NetFeeAmt USD 13,411.98 2026-10-13 S-8 2026-10-15 0001193125-26-421986
ffd TtlFeeAmt TtlFeeAmt USD 13,411.98 2026-10-13 S-8 2026-10-15 0001193125-26-421986
ffd TtlOfferingAmt TtlOfferingAmt USD 154.16M 2026-10-13 S-8 2026-10-15 0001193125-26-421986
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-10-13 S-8 2026-10-15 0001193125-26-421986
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 13,810 2026-10-08 S-1/A 2026-10-08 0001193125-26-417416
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 4.30M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 733,000 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 4.97M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 38,000 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 14.63M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 3.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 3.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 36.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap Assets Assets USD 332.09M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap AssetsCurrent Assets, Current USD 315.93M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 269,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 252.03M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 252.60M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 252.60M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 72.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 33.73M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 238.10M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 4.64M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 4.64M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap CommonStockValue Common Stock, Value, Issued USD 4,000 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -88.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 96.07M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination USD 99.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 8.62M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 76.87M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 4.00M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 44.79M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 51.28M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 1.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 1.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -20.37 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -20.37 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 14,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 5.01M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 13.70M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 76,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 16.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -88.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 2,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap IncreaseDecreaseInAccountsAndOtherReceivables Increase (Decrease) in Accounts and Other Receivables USD 54.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 603,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 75.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 531,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 8,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 5.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap Liabilities Liabilities USD 207.19M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 332.09M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap LiabilitiesCurrent Liabilities, Current USD 74.89M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap LiabilitiesFairValueAdjustment Liabilities, Fair Value Adjustment USD -10.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 120.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -5.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -43.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -88.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -5.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap OperatingExpenses Operating Expenses USD 107.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -83.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 743,000 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 4.14M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 4.46M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 2.11M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 14,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 14,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 5.13M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 9,000 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -52,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 5.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap PreferredStockDividendsPerShareDeclared Preferred Stock, Dividends Per Share, Declared USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 8.09M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 66.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 2.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -88.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 14.00M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 9.03M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 50.90M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 91.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 562,000 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -283.81M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 24.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 3.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 2.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 7.3 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 3.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -269.14M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 2.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 394.04M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 395.29M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 181.32M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 28.52M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 28.52M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap UnbilledReceivablesCurrent Unbilled Receivables, Current USD 4.90M 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 4.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 4.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-19 0001193125-26-468537

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →